Các bài nghiên cứu mới về COVID-19 từ ngày 6/8 đến ngày 13/8/2021

Cục Thông tin KH&CN Quốc gia trân trọng kính gửi đến các nhà khoa học những nghiên cứu mới nhất về COVID-19 trên thế giới. Bao gồm những bài viết đã được xuất bản chính thức và các bài viết được chấp nhận đăng trên những cơ sở dữ liệu học thuật chính thống từ ngày 6/8 đến ngày 13/82021. Những nghiên cứu công bố trước thời gian này được tổng hợp tại đường link cuối bài.

SCIENCEDIRECT

1. Expression, purification and immunological characterization of recombinant nucleocapsid protein fragment from SARS-CoV-2                

Virology, 9 February 2021, Volume 557 (Cover date: May 2021), Pages 15-22

Teodora Djukic, Maja Mladenovic, Tanja Cirkovic Velickovic

https://www.sciencedirect.com/science/article/pii/S004268222100012X/pdfft?md5=324081ca4494fee185f6bb567d004428&pid=1-s2.0-S004268222100012X-main.pdf

2. Evaluation of the susceptibility and fatality of lung cancer patients towards the COVID-19 infection: A systemic approach through analyzing the ACE2, CXCL10 and their co-expressed genes

Current Research in Microbial Sciences, 9 February 2021, Volume 2 (Cover date: December 2021), Article 100022

Tousif Bin Mahmood, Afrin Sultana Chowdhury, Mohammad Imran Hossan

https://www.sciencedirect.com/science/article/pii/S2666517421000031/pdfft?md5=efd4d1354e5abd7f170d382892e0b66a&pid=1-s2.0-S2666517421000031-main.pdf

3. Assay dependence of long-term kinetics of SARS-CoV-2 antibodies

Diagnostic Microbiology and Infectious Disease, 22 April 2021Volume 100, Issue 4 (Cover date: August 2021), Article 115403

Anneleen Schallier, Sarah De Baets, Pedro Couck

https://www.sciencedirect.com/science/article/pii/S0732889321000961/pdfft?md5=94aa8083bf5e7419e7c5a7276a707659&pid=1-s2.0-S0732889321000961-main.pdf

4. Serum cytokine levels of COVID-19 patients after 7 days of treatment with Favipiravir or Kaletra

International Immunopharmacology, 22 January 2021, Volume 93 (Cover date: April 2021), Article 107407

Esmaeil Mortaz, Ali Bassir, Ian M. Adcock

https://www.sciencedirect.com/science/article/pii/S1567576921000436/pdfft?md5=61eefb6914f73e6bc202616df2d679e5&pid=1-s2.0-S1567576921000436-main.pdf

5. Pronounce expression of Tim-3 and CD39 but not PD1 defines CD8 T cells in critical Covid-19 patients

Microbial Pathogenesis, 4 February 2021, Volume 153 (Cover date: April 2021), Article 104779

Mehdi Shahbazi, Zahra Moulana, Mousa Mohammadnia-Afrouzi

https://www.sciencedirect.com/science/article/pii/S0882401021000516/pdfft?md5=c2c9c2b29922b0a556a3a83e56c737ae&pid=1-s2.0-S0882401021000516-main.pdf

6. Candesartan as a tentative treatment for COVID-19: A prospective non-randomized open-label study

International Journal of Infectious Diseases, 24 May 2021, Volume 108 (Cover date: July 2021), Pages 159-166

Antonia Anna Lukito, Allen Widysanto, Irawan Yusuf

https://www.sciencedirect.com/science/article/pii/S1201971221004203/pdfft?md5=9b391516038fba049162734790a5d04d&pid=1-s2.0-S1201971221004203-main.pdf

7. Early multidrug treatment of SARS-CoV-2 infection (COVID-19) and reduced mortality among nursing home (or outpatient/ambulatory) residents

Medical Hypotheses, 5 June 2021, Volume 153 (Cover date: August 2021), Article 110622

Paul E. Alexander, Robin Armstrong, Kulvinder K. Gill

https://www.sciencedirect.com/science/article/pii/S0306987721001419/pdfft?md5=fc05ca3a0568f4948ffbf37195da3da8&pid=1-s2.0-S0306987721001419-main.pdf

8. Soluble ACE2-mediated cell entry of SARS-CoV-2 via interaction with proteins related to the renin-angiotensin system

Cell, 2 March 2021, Volume 184, Issue 8 (Cover date: 15 April 2021), Pages 2212-2228.e12

Man Lung Yeung, Jade Lee Lee Teng, Kwok-Yung Yuen

https://www.sciencedirect.com/science/article/pii/S009286742100283X/pdfft?md5=47997610ceaec1876d55387b1986d3d0&pid=1-s2.0-S009286742100283X-main.pdf

9. Epidemiological and clinical presentations of hospitalized COVID-19 patients in Libya: An initial report from Africa

Travel Medicine and Infectious Disease, 18 April 2021, Volume 42 (Cover date: July–August 2021), Article 102064

Muhammed Elhadi, Ahmed Abdulhakim Momen, Hazem Abdelkarem Faraj

https://www.sciencedirect.com/science/article/pii/S1477893921001058/pdfft?md5=13815dfe5ce7c3e48cf6e23507bbeb4f&pid=1-s2.0-S1477893921001058-main.pdf

10. Comparison of four PCR and two point of care assays used in the laboratory detection of SARS-CoV-2

Journal of Virological Methods, 16 April 2021, Volume 293 (Cover date: July 2021), Article 114165

Bence Kenyeres, Noel Ánosi, György Lengyel

https://www.sciencedirect.com/science/article/pii/S016609342100104X/pdfft?md5=6592969edd82cf1fd9297e1559604322&pid=1-s2.0-S016609342100104X-main.pdf

11. SARS-CoV-2 infection in patients with primary mitochondrial diseases: Features and outcomes in Italy

Mitochondrion, 30 March 2021, Volume 58 (Cover date: May 2021), Pages 243-245

Michelangelo Mancuso, Chiara La Morgia, Valerio Carelli

https://www.sciencedirect.com/science/article/pii/S156772492100043X/pdfft?md5=8437a79bf1d116aa0790240cf73f3981&pid=1-s2.0-S156772492100043X-main.pdf

12. Heparin prevents in vitro glycocalyx shedding induced by plasma from COVID-19 patients

Life Sciences, 27 March 2021, Volume 276 (Cover date: 1 July 2021), Article 119376

Simone R. Potje, Tiago J. Costa, Rita C. Tostes

https://www.sciencedirect.com/science/article/pii/S0024320521003611/pdfft?md5=6f4cb76eeb0d09d40f9ce438c2717300&pid=1-s2.0-S0024320521003611-main.pdf

13. The contrasting role of nasopharyngeal angiotensin converting enzyme 2 (ACE2) transcription in SARS-CoV-2 infection: A cross-sectional study of people tested for COVID-19 in British Columbia, Canada

EBioMedicine, 2 April 2021, Volume 66 (Cover date: April 2021), Article 103316

Aidan M. Nikiforuk, Kevin S. Kuchinski, Inna Sekirov

https://www.sciencedirect.com/science/article/pii/S2352396421001092/pdfft?md5=04cdacfd1722edae23829ef313a986b6&pid=1-s2.0-S2352396421001092-main.pdf

14. Liver histopathology in COVID-19 patients: A mono-Institutional series of liver biopsies and autopsy specimens

Pathology - Research and Practice, 19 April 2021, Volume 221 (Cover date: May 2021), Article 153451

Matteo Fassan, Claudia Mescoli, Angelo Paolo Dei Tos

https://www.sciencedirect.com/science/article/pii/S0344033821001126/pdfft?md5=5d815f24bdd86f2a48f1aaea9bc01f6a&pid=1-s2.0-S0344033821001126-main.pdf

15. Comparative research on nucleocapsid and spike glycoprotein as the rapid immunodetection targets of COVID-19 and establishment of immunoassay strips

Molecular Immunology, 9 January 2021, Volume 131 (Cover date: March 2021), Pages 6-12

Dan Liu, Feng Wu, Lan Ma

https://www.sciencedirect.com/science/article/pii/S0161589021000055/pdfft?md5=0d76ffac90425eac0d76d0186d9469ce&pid=1-s2.0-S0161589021000055-main.pdf

16. A rapid diagnosis of SARS-CoV-2 using DNA hydrogel formation on microfluidic pores

Biosensors and Bioelectronics, 18 January 2021, Volume 177 (Cover date: 1 April 2021), Article 113005

Hwang-soo Kim, Naseem Abbas, Sehyun Shin

https://www.sciencedirect.com/science/article/pii/S0956566321000415/pdfft?md5=e2e750792076f189cc66befa23ec9567&pid=1-s2.0-S0956566321000415-main.pdf

17. Cutaneous manifestations associated with anosmia, ageusia and enteritis in SARS-CoV-2 infection - A possible pattern? Observational study and review of the literature

International Journal of Infectious Diseases, 19 April 2021, Volume 107 (Cover date: June 2021), Pages 72-77

Victoria Birlutiu, Alin Iulian Feiereisz, Gabriela Mariana Iancu

https://www.sciencedirect.com/science/article/pii/S1201971221003702/pdfft?md5=c80daf5f611596dfcb73bc8ef837c768&pid=1-s2.0-S1201971221003702-main.pdf

18. C5aR inhibition of nonimmune cells suppresses inflammation and maintains epithelial integrity in SARS-CoV-2–infected primary human airway epithelia

Journal of Allergy and Clinical Immunology, 20 April 2021, Volume 147, Issue 6 (Cover date: June 2021), Pages 2083-2097.e6

Wilfried Posch, Jonathan Vosper, Doris Wilflingseder

https://www.sciencedirect.com/science/article/pii/S0091674921005601/pdfft?md5=31b89db42b9e6bcfc92c339a3e8fec9c&pid=1-s2.0-S0091674921005601-main.pdf

19. Dual inhibition of SARS-CoV-2 and human rhinovirus with protease inhibitors in clinical development

Antiviral Research, 27 January 2021, Volume 187 (Cover date: March 2021), Article 105020

Cheng Liu, Sandro Boland, Jerome Deval

https://www.sciencedirect.com/science/article/pii/S0166354221000103/pdfft?md5=282737669a5805207aead53102a7dda4&pid=1-s2.0-S0166354221000103-main.pdf

20. Coronavirus disease 2019 vaccine mimics lymph node metastases in patients undergoing skin cancer follow-up: A monocentre study

European Journal of Cancer, 26 June 2021, Volume 154 (Cover date: September 2021), Pages 167-174

Jan-Malte Placke, Henning Reis, Joachim Klode

https://www.sciencedirect.com/science/article/pii/S0959804921003981/pdfft?md5=b67241b5741d3bd9065fbc983394d370&pid=1-s2.0-S0959804921003981-main.pdf

21. How Should the World Pay for a Coronavirus Disease (COVID-19) Vaccine?

Value in Health, 19 February 2021, Volume 24, Issue 5 (Cover date: May 2021), Pages 625-631

Adrian Towse, Kalipso Chalkidou, Rachel Silverman

https://www.sciencedirect.com/science/article/pii/S1098301521000322/pdfft?md5=13164bad0d5bb27a20c7db5de548ee52&pid=1-s2.0-S1098301521000322-main.pdf

22. Attitudes towards COVID-19 vaccine and reasons for adherence or not among nursing students

Journal of Professional Nursing, 17 July 2021, Volume 37, Issue 5 (Cover date: September–October 2021), Pages 923-927

Michael Belingheri, Davide Ausili, Michele A. Riva

https://www.sciencedirect.com/science/article/pii/S8755722321001162/pdfft?md5=e04b6b777ee9f04eb0684eddd0d4c607&pid=1-s2.0-S8755722321001162-main.pdf

23. Assessing the quality of COVID-19 vaccine videos on video-sharing platforms

Exploratory Research in Clinical and Social Pharmacy, June 2021, Volume 2, Article 100035

Ryan Yanqi Tan, Alyssa Elyn Pua, Kevin Yi-Lwern Yap

https://www.sciencedirect.com/science/article/pii/S2667276621000354/pdfft?md5=0f63cc84dae4bcafafdd8b3a042228a7&pid=1-s2.0-S2667276621000354-main.pdf

24. Projected COVID-19 epidemic in the United States in the context of the effectiveness of a potential vaccine and implications for social distancing and face mask use

Vaccine, 27 February 2021, Volume 39, Issue 16 (Cover date: 15 April 2021), Pages 2295-2302

Mingwang Shen, Jian Zu, Lei Zhang

https://www.sciencedirect.com/science/article/pii/S0264410X2100236X/pdfft?md5=d0d4c4f8b96eff467a40475644d9a58e&pid=1-s2.0-S0264410X2100236X-main.pdf

25. NIH funding for vaccine readiness before the COVID-19 pandemic

Vaccine, 8 March 2021, Volume 39, Issue 17 (Cover date: 22 April 2021), Pages 2458-2466

Anthony E. Kiszewski, Ekaterina Galkina Cleary, Fred D. Ledley

https://www.sciencedirect.com/science/article/pii/S0264410X21002905/pdfft?md5=33ba8b1f77b0a76989bb365af6e1c172&pid=1-s2.0-S0264410X21002905-main.pdf

26. A single intranasal or intramuscular immunization with chimpanzee adenovirus-vectored SARS-CoV-2 vaccine protects against pneumonia in hamsters

Cell Reports, 29 June 2021, Volume 36, Issue 3 (Cover date: 20 July 2021), Article 109400

Traci L. Bricker, Tamarand L. Darling, Adrianus C. M. Boon

https://www.sciencedirect.com/science/article/pii/S2211124721007981/pdfft?md5=c0861986c4959f37f75cfc10d5e77042&pid=1-s2.0-S2211124721007981-main.pdf

27. Key points to keep in mind related to COVID-19 vaccines in people with multiple sclerosis

Multiple Sclerosis and Related Disorders, 16 July 2021, Volume 54 (Cover date: September 2021), Article 103142

Lorna Galleguillos, Ricardo Alonso

https://www.sciencedirect.com/science/article/pii/S2211034821004090/pdfft?md5=b73dfc1c94879198c6ef5f4a08f5682e&pid=1-s2.0-S2211034821004090-main.pdf

28. COVID-19 vaccine hesitancy in adults with multiple sclerosis in the United States: A follow up survey during the initial vaccine rollout in 2021

Multiple Sclerosis and Related Disorders, 22 July 2021, Volume 54 (Cover date: September 2021), Article 103163

Dawn M. Ehde, Michelle K. Roberts, Kevin N. Alschuler

https://www.sciencedirect.com/science/article/pii/S2211034821004302/pdfft?md5=c2f8993d823bd5792df2baae4376b4ab&pid=1-s2.0-S2211034821004302-main.pdf

29. A new fractional mathematical modelling of COVID-19 with the availability of vaccine

Results in Physics, 20 April 2021, Volume 24 (Cover date: May 2021), Article 104213

Pushpendra Kumar, Vedat Suat Erturk, Marina Murillo-Arcila

https://www.sciencedirect.com/science/article/pii/S2211379721003582/pdfft?md5=f595011c5ce463b43c7962c1562cf282&pid=1-s2.0-S2211379721003582-main.pdf

30. An in-depth in silico and immunoinformatics approach for designing a potential multi-epitope construct for the effective development of vaccine to combat against SARS-CoV-2 encompassing variants of concern and interest

Computers in Biology and Medicine, 30 July 2021, Volume 136 (Cover date: September 2021), Article 104703

Abdullah Al Saba, Maisha Adiba, A. H. M. Nurun Nabi

https://www.sciencedirect.com/science/article/pii/S0010482521004972/pdfft?md5=72086c516e81eaed83233e1ee5869dd3&pid=1-s2.0-S0010482521004972-main.pdf

31. Predictors of COVID-19 vaccine hesitancy in the UK household longitudinal study

Brain, Behavior, and Immunity, 11 March 2021, Volume 94 (Cover date: May 2021, )Pages 41-50

Elaine Robertson, Kelly S. Reeve, Michaela J. Benzeval

https://www.sciencedirect.com/science/article/pii/S0889159121001100/pdfft?md5=293d047a2e1c01ce43ac70f4c374aca3&pid=1-s2.0-S0889159121001100-main.pdf

32. Factors associated with COVID-19 vaccine trust and hesitancy among adults with chronic conditions

Preventive Medicine Reports, 15 July 2021, Volume 24 (Cover date: December 2021), Article 101484

Marina Arvanitis, Lauren Opsasnick, Michael S. Wolf

https://www.sciencedirect.com/science/article/pii/S2211335521001741/pdfft?md5=da4c759a24832c4d3385735882c1b0fd&pid=1-s2.0-S2211335521001741-main.pdf

33. Development of safe and highly protective live-attenuated SARS-CoV-2 vaccine candidates by genome recoding

Cell Reports, 20 July 2021, Volume 36, Issue 5 (Cover date: 3 August 2021), Article 109493

Jakob Trimpert, Kristina Dietert, Dusan Kunec

https://www.sciencedirect.com/science/article/pii/S2211124721009207/pdfft?md5=77635112aaa709fe1548c2af33e3429b&pid=1-s2.0-S2211124721009207-main.pdf

34. Trajectories of COVID-19 vaccine intentions among U.S. adults: The role of race and ethnicity

SSM - Population Health, 27 May 2021, Volume 15 (Cover date: September 2021), Article 100824

Michael D. Niño, Brittany N. Hearne, Tianji Cai

https://www.sciencedirect.com/science/article/pii/S2352827321000999/pdfft?md5=95b71bd906a75c609e0f5e56bc710c08&pid=1-s2.0-S2352827321000999-main.pdf

35. Patient-reported safety and tolerability of the COVID-19 vaccines in persons with rare neuroimmunological diseases

Multiple Sclerosis and Related Disorders, 2 August 2021, Volume 55 (Cover date: October 2021), Article 103189

Itay Lotan, Gabriela Romanow, Michael Levy

https://www.sciencedirect.com/science/article/pii/S2211034821004569/pdfft?md5=2564162fa5c214fc9550df876149757f&pid=1-s2.0-S2211034821004569-main.pdf

36. A single dose of the SARS-CoV-2 vaccine BNT162b2 elicits Fc-mediated antibody effector functions and T cell responses

Cell Host & Microbe, 4 June 2021, Volume 29, Issue 7 (Cover date: 14 July 2021), Pages 1137-1150.e6

Alexandra Tauzin, Manon Nayrac, Andrés Finzi

https://www.sciencedirect.com/science/article/abs/pii/S1931312821002791

37. Nanocarrier vaccines for SARS-CoV-2

Advanced Drug Delivery Reviews, 9 January 2021, Volume 171 (Cover date: April 2021), Pages 215-239

Jatin Machhi, Farah Shahjin, Bhavesh D. Kevadiya

https://www.sciencedirect.com/science/article/abs/pii/S0169409X21000028

38. SARS-CoV-2 vaccine-induced cerebral venous thrombosis

European Journal of Internal Medicine, 25 May 2021, Volume 89 (Cover date: July 2021), Pages 19-21

Alfonso Ciccone

https://www.sciencedirect.com/science/article/abs/pii/S0953620521001850

39. Professionally responsible coronavirus disease 2019 vaccination counseling of obstetrical and gynecologic patients

American Journal of Obstetrics and Gynecology, 1 February 2021, Volume 224, Issue 5 (Cover date: May 2021), Pages 470-478

Frank A. Chervenak, Laurence B. McCullough, Amos Grünebaum

https://www.sciencedirect.com/science/article/abs/pii/S000293782100082X

40. The investigation of mRNA vaccines formulated in liposomes administrated in multiple routes against SARS-CoV-2

Journal of Controlled Release, 21 May 2021, Volume 335 (Cover date: 10 July 2021), Pages 449-456

Hai Huang, Caili Zhang, Xiangrong Song

https://www.sciencedirect.com/science/article/abs/pii/S0168365921002406

41. A modified vaccinia Ankara vector-based vaccine protects macaques from SARS-CoV-2 infection, immune pathology, and dysfunction in the lungs

Immunity, 4 February 2021, Volume 54, Issue 3 (Cover date: 9 March 2021), Pages 542-556.e9

Nanda Kishore Routhu, Narayanaiah Cheedarla, Rama Rao Amara

https://www.sciencedirect.com/science/article/abs/pii/S107476132100042X

42.  Effectiveness of ChAdOx1 nCOV-19 Vaccine: Experience of a tertiary care institute

Medical Journal Armed Forces India, 26 July 2021, Volume 77, Supplement 2 (Cover date: July 2021), Pages s271-s277

Saurabh Bobdey, S. K. Kaushik, Santosh Karade

https://www.sciencedirect.com/science/article/pii/S0377123721001520

43. Blood clots and bleeding events following BNT162b2 and ChAdOx1 nCoV-19 vaccine: An analysis of European data

Journal of Autoimmunity, 23 June 2021, Volume 122 (Cover date: August 2021), Article 102685

Luigi Cari, Paolo Fiore, Giuseppe Nocentini

https://www.sciencedirect.com/science/article/pii/S0896841121000937

44. Initial observations on age, gender, BMI and hypertension in antibody responses to SARS-CoV-2 BNT162b2 vaccine

EClinicalMedicine, 4 June 2021, Volume 36 (Cover date: June 2021), Article 100928

Raul Pellini, Aldo Venuti, Gennaro Ciliberto

https://www.sciencedirect.com/science/article/pii/S258953702100208X/pdfft?md5=2988c0c720fbab718a9d42cf201961b3&pid=1-s2.0-S258953702100208X-main.pdf

45. Innovative trial designs and analyses for vaccine clinical development

Contemporary Clinical Trials, 21 November 2020, Volume 100 (Cover date: January 2021), Article 106225

Mengya Liu, Qing Li, Elaine Hoffman

https://www.sciencedirect.com/science/article/pii/S1551714420303037

46. Vaccine-escape and fast-growing mutations in the United Kingdom, the United States, Singapore, Spain, India, and other COVID-19-devastated countries

Genomics, 15 May 2021, Volume 113, Issue 4 (Cover date: July 2021), Pages 2158-2170

Rui Wang, Jiahui Chen, Guo-Wei Wei

https://www.sciencedirect.com/science/article/abs/pii/S0888754321001798

47. Immunogenomics guided design of immunomodulatory multi-epitope subunit vaccine against the SARS-CoV-2 new variants, and its validation through in silico cloning and immune simulation

Computers in Biology and Medicine, 24 April 2021, Volume 133 (Cover date: June 2021), Article 104420

Abbas Khan, Shahzeb Khan, Dong-Qing Wei

https://www.sciencedirect.com/science/article/abs/pii/S0010482521002146

48. Is the BCG vaccine a useful tool against COVID-19?

Clinics in Dermatology, 16 December 2020, Volume 39, Issue 1 (Cover date: January–February 2021), Pages 98-103

Galina Zhelezova, Valeria Mateeva, Grisha Mateev

https://www.sciencedirect.com/science/article/abs/pii/S0738081X20302534

49. Lipid-based vaccine nanoparticles for induction of humoral immune responses against HIV-1 and SARS-CoV-2

Journal of Controlled Release, 20 December 2020, Volume 330 (Cover date: 10 February 2021), Pages 529-539

Kyung Soo Park, Joseph D. Bazzill, James J. Moon

https://www.sciencedirect.com/science/article/abs/pii/S0168365920307550

50. Virology, epidemiology, immunology and vaccine development of SARS-CoV-2, update after nine months of pandemic

Biologicals, 19 November 2020, Volume 69 (Cover date: January 2021), Pages 76-82

Marc Baay, Bruno Lina, Pieter Neels

https://www.sciencedirect.com/science/article/pii/S1045105620301378/pdfft?md5=dc8e5118e8fbd47011896e0cb404b499&pid=1-s2.0-S1045105620301378-main.pdf

51. Immuno-informatics approach for B-cell and T-cell epitope based peptide vaccine design against novel COVID-19 virus

Vaccine, 9 January 2021, Volume 39, Issue 7 (Cover date: 12 February 2021), Pages 1087-1095

Jitender Singh, Deepti Malik, Ashvinder Raina

https://www.sciencedirect.com/science/article/pii/S0264410X21000153

52. An intranasal vaccine durably protects against SARS-CoV-2 variants in mice

Cell Reports, 10 July 2021, Volume 36, Issue 4 (Cover date: 27 July 2021), Article 109452

Ahmed O. Hassan, Swathi Shrihari, Michael S. Diamond

https://www.sciencedirect.com/science/article/pii/S221112472100869X/pdfft?md5=d114eb70b15d8311980dfaa36e1d5696&pid=1-s2.0-S221112472100869X-main.pdf

53. Planning for monitoring the introduction and effectiveness of new vaccines using real-word data and geospatial visualization: An example using rotavirus vaccines with potential application to SARS-CoV-2

Vaccine: X9 January 2021, Volume 7 (Cover date: April 2021), Article 100084

T. Christopher Mast, David Heyman, Lyn Finelli

https://www.sciencedirect.com/science/article/pii/S2590136221000012/pdfft?md5=9e892e84765508574f31df5d320e21ca&pid=1-s2.0-S2590136221000012-main.pdf

54. Safety and immunogenicity of INO-4800 DNA vaccine against SARS-CoV-2: A preliminary report of an open-label, Phase 1 clinical trial

EClinicalMedicine, 24 December 2020, Volume 31 (Cover date: January 2021), Article 100689

Pablo Tebas, ShuPing Yang, Laurent M. Humeau

https://www.sciencedirect.com/science/article/pii/S2589537020304338/pdfft?md5=cf753d416d26cce06df38c7864654db0&pid=1-s2.0-S2589537020304338-main.pdf

55. Engineering a self-navigated MnARK nanovaccine for inducing potent protective immunity against novel coronavirus

Nano Today, 19 March 2021, Volume 38 (Cover date: June 2021), Article 101139

Yaling Wang, Yuping Xie, Chunying Chen

https://www.sciencedirect.com/science/article/abs/pii/S1748013221000645

WILEY:

1. Prognostic implications of biventricular strain measurement in COVID-19 patients by speckle-tracking echocardiography

Mohammad Khani MD, Sasan Tavana MD, Mohammadreza Tabary MD, Zahra Naseri Kivi MD, Isa Khaheshi MD                                       

Clinical Cardiology                                       

First published: 06 August 2021                                             

https://onlinelibrary.wiley.com/doi/epdf/10.1002/clc.23708

2. A pair of non-competing neutralizing human monoclonal antibodies protecting from disease in a SARS-CoV-2 infection model

Antonia Sophia Peter, Edith Roth, Sebastian R. Schulz, Kirsten Fraedrich, Tobit Steinmetz, Dominik Damm, Manuela Hauke, Elie Richel, Sandra Mueller-Schmucker, Katharina Habenicht, Valentina Eberlein,…

European Journal of Immunology

First published: 06 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/eji.202149374

3. Decline in Sars‐CoV‐2 antibodies over 6 month follow up in Obstetrical Healthcare workers

Miranda K. Kiefer DO, Kenneth D. Allen DO, Jessica R. Russo, Marwan Ma'ayeh MD, Stephen E. Gee MD, Doug Kniss PhD, Michael Cackovic MD, Maged M. Costantine MD, Kara M. Rood MD

American Journal of Reproductive Immunology

First published: 06 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/aji.13490

4. Prognostic utility of pulmonary artery and ascending aorta diameters derived from computed tomography in COVID-19 patients

Mehmet Erdoğan MD, Selçuk Öztürk MD, Mehmet Akif Erdöl MD, Ahmet Kasapkara MD, Muhammed Said Beşler, Bircan Kayaaslan MD, İmran Hasanoğlu MD, Tahir Durmaz MD, Rahmet Güner MD

Echocardiography

First published: 06 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/echo.15170

5. Relationship between echocardiographic tricuspid annular plane systolic excursion and mortality in COVID-19 patients: A Meta-analysis

Marco Zuin MD, Gianluca Rigatelli MD PhD, Loris Roncon MD, Giovanni Zuliani MD PhD

Echocardiography

First published: 06 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/echo.15175

6. Repetitive saliva-based mass screening as a tool for controlling SARS-CoV-2 transmission in nursing homes

Claude Saegerman, Anne-Françoise Donneau, Niko Speybroeck, Anh Nguyet Diep, Alexandria Williams, Lambert Stamatakis, Wouter Coppieters, Fabienne Michel, Christophe Breuer, Margaux Dandoy, Olivier Ek, Claire Gourzones, Joey Schyns, Emeline Goffin, Frédéric Minner, Véronique Renault, Laurent Gillet, Fabrice Bureau

Transboundary and Emerging Diseases

First published: 06 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/tbed.14280

7. New pyrazine conjugates: Synthesis, computational studies, and antiviral properties against SARS‐CoV‐2

Israa A. Seliem, Adel S. Girgis, Yassmin Moatasim, Ahmed Kandeil, Ahmed Mostafa, Mohamed A. Ali, Mohamed S. Bekheit, Siva S Panda

ChemMedChem

First published: 05 August 2021

https://chemistry-europe.onlinelibrary.wiley.com/doi/epdf/10.1002/cmdc.202100476

8. Therapeutic interventions of remdesivir in diabetic and non-diabetic COVID-19 patients: A prospective observational study conducted on Pakistani population

Qiadat Hasnain Qureshi, Taimoor Ashraf, Kanwal Rehman, Muhammad Kaleem Khosa, Muhammad Sajid Hamid Akash

Journal of Medical Virology

First published: 05 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1002/jmv.27256

9. Comprehensive investigation of RNA-sequencing dataset reveals the hub genes and molecular mechanisms of coronavirus disease 2019 acute respiratory distress syndrome

Wangsheng Deng, Jiaxing Zeng, Shunyu Lu, Chaoqian Li

IET Systems Biology

First published: 05 August 2021

https://ietresearch.onlinelibrary.wiley.com/doi/epdf/10.1049/syb2.12034

10. Incidence and risk factors for persistent symptoms in adults previously hospitalised for COVID-19

Daniel Munblit, Polina Bobkova, Ekaterina Spiridonova, Anastasia Shikhaleva, Aysylu Gamirova, Oleg Blyuss, Nikita Nekliudov, Polina Bugaeva, Margarita Andreeva, Audrey DunnGalvin…

Clinical & Experimental Allergy

First published: 05 August 2021

https://onlinelibrary.wiley.com/doi/epdf/10.1111/cea.13997

SPRINGER NATURE

1. Cumulative Adverse Event Reporting of Anaphylaxis After mRNA COVID-19 Vaccine (Pfizer-BioNTech) Injections in Japan: The First-Month Report

Toyotaka Iguchi, Hikari Umeda, Michie Kojima, Yuri Kanno, Yuta Tanaka… in Drug Safety (2021)

https://link.springer.com/content/pdf/10.1007%2Fs40264-021-01104-9.pdf

2. Cell-Based Therapy for Severe COVID-19 Patients: Clinical Trials and Cost-Utility

Ali Golchin in Stem Cell Reviews and Reports (2021)

https://link.springer.com/content/pdf/10.1007%2Fs12015-020-10046-1.pdf

3. Immunoinformatics approach for multi-epitope vaccine design against structural proteins and ORF1a polyprotein of severe acute respiratory syndrome coronavirus-2 (SARS-CoV-2)

Khalid Mohamed Adam in Tropical Diseases, Travel Medicine and Vaccines (2021)

https://link.springer.com/content/pdf/10.1186%2Fs40794-021-00147-1.pdf

4. Headache Attributed to Vaccination Against COVID-19 (Coronavirus SARS-CoV-2) with the ChAdOx1 nCoV-19 (AZD1222) Vaccine: A Multicenter Observational Cohort Study

Carl H. Göbel, Axel Heinze, Sarah Karstedt, Mascha Morscheck… in Pain and Therapy (2021)

https://link.springer.com/content/pdf/10.1007%2Fs40122-021-00296-3.pdf

5. Cerebral venous sinus thrombosis 2 weeks after the first dose of mRNA SARS-CoV-2 vaccine

Zaitun Zakaria, Nur Asma Sapiai, Abdul Rahman Izaini Ghani in Acta Neurochirurgica (2021)

https://link.springer.com/content/pdf/10.1007%2Fs00701-021-04860-w.pdf

6. Peptide enzyme‐linked immunosorbent assay (pELISA) as a possible alternative to the neutralization test for evaluating the immune response to IBV vaccine

Qi Wu, Zhixian Lin, Jinsen Wu, Kun Qian, Hongxia Shao… in BMC Veterinary Research (2021)

https://link.springer.com/content/pdf/10.1186%2Fs12917-021-02757-5.pdf

7. COVID-19 vaccine acceptance among pregnant women and mothers of young children: results of a survey in 16 countries

Malia Skjefte, Michelle Ngirbabul, Oluwasefunmi Akeju… in European Journal of Epidemiology (2021)

https://link.springer.com/content/pdf/10.1007%2Fs10654-021-00728-6.pdf

8. Glucocorticoid use in patients with adrenal insufficiency following administration of the COVID-19 vaccine: a pituitary society statement

Laurence Katznelson, Mônica Gadelha in Pituitary (2021)

https://link.springer.com/content/pdf/10.1007%2Fs11102-021-01130-x.pdf

9. On BCG Vaccine Protection from COVID-19: A Review

Narges Bagheri, Hesam Montazeri in SN Comprehensive Clinical Medicine (2021)

https://link.springer.com/content/pdf/10.1007%2Fs42399-021-00835-1.pdf

10. Psychometric Properties of a Vaccine Hesitancy Scale Adapted for COVID-19 Vaccination Among People with HIV

Violeta J. Rodriguez, Maria L. Alcaide, Ana S. Salazar… in AIDS and Behavior (2021)

https://link.springer.com/content/pdf/10.1007%2Fs10461-021-03350-5.pdf

Các công bố về COVID-19 trước thời gian trên:

Cập nhật các công bố về COVID-19 từ ngày 30/07 đến ngày 06/08/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-7-den-ngay-6-8-2021-3849.html

Cập nhật các công bố về COVID-19 từ ngày 23/07 đến ngày 30/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-7-den-ngay-30-7-2021-3823.html

Cập nhật các công bố về COVID-19 từ ngày 16/07 đến ngày 23/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-07-den-ngay-23-07-2021-3797.html

Cập nhật các công bố về COVID-19 từ ngày 09/07 đến ngày 16/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-07-den-ngay-16-07-2021-3769.html

Cập nhật các công bố về COVID-19 từ ngày 02/07 đến ngày 09/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-7-2021-den-ngay-9-7-2021-3744.html

Cập nhật các công bố về COVID-19 từ ngày 25/06 đến ngày 02/07/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-25-6-den-ngay-02-7-2021-3716.html

Cập nhật các công bố về COVID-19 từ ngày 18/06 đến ngày 25/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-6-den-ngay-25-6-2021-3692.html

Cập nhật các công bố về COVID-19 từ ngày 11/06 đến ngày 18/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-11-06-den-ngay-18-06-2021-3663.html

Cập nhật các công bố về COVID-19 từ ngày 04/06 đến ngày 11/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-04-06-den-ngay-11-6-2021-3642.html

Cập nhật các công bố về COVID-19 từ ngày 28/05 đến ngày 04/06/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-28-05-den-ngay-04-06-2021-3624.html

Cập nhật các công bố về COVID-19 từ ngày 21/05 đến ngày 28/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-05-den-ngay-28-05-2021-3598.html

Cập nhật các công bố về COVID-19 từ ngày 14/05 đến ngày 21/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-14-05-den-ngay-21-05-2021-3582.html

Cập nhật các công bố về COVID-19 từ ngày 07/05 đến ngày 14/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-05-den-ngay-14-05-2021-3557.html

Cập nhật các công bố về COVID-19 từ ngày 30/04 đến ngày 07/05/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-04-den-ngay-07-05-2021-3530.html

Cập nhật các công bố về COVID-19 từ ngày 23/04 đến ngày 30/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-04-den-ngay-30-04-2021-3509.html

Cập nhật các công bố về COVID-19 từ ngày 16/04 đến ngày 23/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-16-04-den-ngay-23-04-2021-3484.html

Cập nhật các công bố về COVID-19 từ ngày 09/04 đến ngày 16/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-04-den-ngay-19-04-2021-3474.html

Cập nhật các công bố về COVID-19 từ ngày 02/04 đến ngày 09/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-04-den-ngay-09-04-2021-3432.html

Cập nhật các công bố về COVID-19 từ ngày 26/03 đến ngày 02/04/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-03-den-ngay-02-04-2021-3408.html

Cập nhật các công bố về COVID-19 từ ngày 19/03 đến ngày 26/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-03-den-ngay-26-03-2021-3386.html

Cập nhật các công bố về COVID-19 từ ngày 12/03 đến ngày 19/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-12-3-den-ngay-19-3-2021-3376.html

Cập nhật các công bố về COVID-19 từ ngày 26/02 đến ngày 04/03/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-02-den-ngay-4-3-2021-3336.html

Cập nhật các công bố về COVID-19 từ ngày 09/02 đến ngày 25/02/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-02-den-ngay-25-02-2021-3319.html

Cập nhật các công bố về COVID-19 từ ngày 23/01 đến ngày 29/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-23-01-den-ngay-29-01-2021-3250.html

Cập nhật các công bố về COVID-19 từ ngày 09/01 đến ngày 15/01/2021

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-09-01-den-ngay-15-01-2021-3211.html

Cập nhật các công bố về COVID-19 từ ngày 18/12 đến ngày 24/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-18-12-den-ngay-24-12-2020-3174.html

Cập nhật các công bố về COVID-19 từ ngày 05/12 đến ngày 17/12/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-12-den-ngay-17-12-2020-3160.html

Cập nhật các công bố về COVID-19 từ ngày 15/11 đến ngày 22/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-11-den-ngay-22-11-2020-3123.html

Cập nhật các công bố về COVID-19 từ ngày 02/10 đến ngày 09/11/2020

https://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-02-10-den-ngay-09-11-2020-3107.html

Cập nhật các công bố về COVID-19 từ ngày 26/9 đến ngày 02/10/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-26-9-den-ngay-02-10-2020-3027.html

Cập nhật các công bố về COVID-19 từ ngày 19/9 đến ngày 25/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-19-9-den-ngay-25-9-2020-3010.html

Cập nhật các công bố về COVID-19 từ ngày 05/9 đến ngày 11/9/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-9-den-ngay-11-9-2020-2969.html

Cập nhật các công bố về COVID-19 từ ngày 29/8 đến ngày 04/9/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-29-8-den-ngay-04-9-2020-2944.html

Cập nhật các công bố về COVID-19 từ ngày 21/8 đến ngày 28/8/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-21-8-den-ngay-28-8-2020-2929.html

Cập nhật các công bố về VACCINE COVID-19 tháng 8 năm 2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-vaccine-covid-19-2900.html

Cập nhật các công bố về COVID-19 từ ngày 08/8 đến ngày 14/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-8-den-ngay-14-8-2020-2866.html

Cập nhật các công bố về COVID-19 từ ngày 27/7 đến ngày 07/8/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-7-den-ngay-07-8-2020-2826.html

Cập nhật các công bố về COVID-19 từ ngày 15/7 đến ngày 26/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-7-den-ngay-26-7-2020-2779.html

Cập nhật các công bố về COVID-19 từ ngày 05/7 đến ngày 13/7/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-05-7-den-ngay-13-7-2020-2723.html

Cập nhật các công bố về COVID-19 từ ngày 22/6 đến ngày 30/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-22-6-den-ngay-30-6-2020-2681.html

Cập nhật các công bố về COVID-19 từ ngày 15/6 đến ngày 21/6/2020

https://www.most.gov.vn/vn/tin-tuc/17959/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-6-den-ngay-21-6-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 07/6 đến ngày 14/6/2020

http://www.vista.gov.vn/news/khoa-hoc-y-duoc/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-07-6-den-ngay-14-6-2020-2580.html

Cập nhật các công bố về COVID-19 đến ngày 07/6/2020

http://www.vista.gov.vn/news/khoa-hoc-ky-thuat-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-01-6-den-ngay-07-6-2020-2553.html

Cập nhật các công bố về COVID-19 đến ngày 01/6/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-den-ngay-01-6-2020-2524.html

Cập nhật các công bố về COVID-19 từ ngày 15/5 tới ngày 21/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-15-5-den-ngay-24-5-2020-2478.html

Cập nhật các công bố về COVID-19 từ ngày 08/5 tới ngày 14/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-08-5-den-ngay-14-5-2020-2436.html

Cập nhật các công bố về COVID-19 từ ngày 30/4 tới ngày 07/5/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-30-4-den-ngay-07-5-2020-2406.html

Cập nhật các công bố về COVID-19 từ ngày 24/4 tới ngày 30/4/2020

http://www.vista.gov.vn/news/cac-linh-vuc-khoa-hoc-va-cong-nghe/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-24-4-den-ngay-30-4-2020-2375.html

Cập nhật các công bố về COVID-19 từ ngày 17/4 tới ngày 23/4/2020

https://www.most.gov.vn/vn/tin-tuc/17695/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-17-4-den-ngay-23-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 10/4 tới ngày 16/4/2020

https://www.most.gov.vn/vn/tin-tuc/17655/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-10-4--den-ngay-16-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 03/4 tới ngày 09/4/2020

https://www.most.gov.vn/vn/tin-tuc/17630/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-3-4--den-ngay-9-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 27/3 tới ngày 02/4/2020

https://www.most.gov.vn/vn/tin-tuc/17609/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-27-3-den-ngay-02-4-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 20/3 tới ngày 26/3/2020

https://www.most.gov.vn/vn/tin-tuc/17597/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-20-3-den-ngay-26-3-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 13/3 tới ngày 19/3/2020

https://www.most.gov.vn/vn/tin-tuc/17575/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-13-3-den-ngay-19-3-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 06/3 tới ngày 12/3/2020

https://www.most.gov.vn/vn/tin-tuc/17547/cac-bai-nghien-cuu-moi-ve-covid-19-tu-ngay-06-3-den-ngay-12-3-2020.aspx

Cập nhật các công bố về COVID-19 từ ngày 28/02 tới ngày 05/3/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20781/language/vi-VN/Default.aspx?seo=Cap-nhat-cac-cong-bo-moi-ve-COVID-19-den-ngay-05/3/2020&language=vi-VN

Cập nhật các công bố về COVID-19 từ ngày 11/02 tới ngày 27/02/2020

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20740/seo/20740/language/vi-VN/language/vi-VN/Default.aspx

Cập nhật các công bố về virus corona từ tháng 11/2019 tới ngày 10/02/2020 

http://www.vista.gov.vn/UserPages/News/detail/tabid/73/newsid/20678/seo/20678/language/vi-VN/Default.aspx

Nguồn: Cục Thông tin KH&CN Quốc gia, ngày 13/8/2021